Luc Darnige

1.7k total citations
69 papers, 971 citations indexed

About

Luc Darnige is a scholar working on Hematology, Rheumatology and Surgery. According to data from OpenAlex, Luc Darnige has authored 69 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 33 papers in Rheumatology and 15 papers in Surgery. Recurrent topics in Luc Darnige's work include Systemic Lupus Erythematosus Research (31 papers), Platelet Disorders and Treatments (25 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Luc Darnige is often cited by papers focused on Systemic Lupus Erythematosus Research (31 papers), Platelet Disorders and Treatments (25 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Luc Darnige collaborates with scholars based in France, Switzerland and Canada. Luc Darnige's co-authors include J Arvieux, Jean‐Claude Bensa, Maurice G. Colomb, Claudine Caron, Guido Reber, Julien Masliah‐Planchon, Sylvia Bellucci, Marie‐Agnès Dragon‐Durey, Pascale Gaussem and Marc Sapoval and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Luc Darnige

66 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc Darnige France 15 540 511 194 161 131 69 971
Teresa Iwaniec Poland 18 350 0.6× 257 0.5× 146 0.8× 115 0.7× 100 0.8× 71 879
Fengchun Zhang China 20 440 0.8× 167 0.3× 193 1.0× 79 0.5× 13 0.1× 68 1.3k
Carolyn Whitsett United States 20 50 0.1× 511 1.0× 197 1.0× 123 0.8× 191 1.5× 45 1.3k
Aşkın Ateş Türkiye 17 324 0.6× 114 0.2× 85 0.4× 45 0.3× 37 0.3× 81 818
Garifallia Sakellariou Italy 20 967 1.8× 285 0.6× 177 0.9× 76 0.5× 8 0.1× 75 1.3k
Stefano Franchini Italy 17 209 0.4× 236 0.5× 136 0.7× 61 0.4× 27 0.2× 30 1.1k
H. Devilliers France 17 637 1.2× 115 0.2× 105 0.5× 47 0.3× 13 0.1× 69 990
Mehmet Turgut Türkiye 15 100 0.2× 473 0.9× 129 0.7× 30 0.2× 28 0.2× 63 834
Russell Buchanan Australia 19 432 0.8× 86 0.2× 111 0.6× 155 1.0× 8 0.1× 54 887
Kimihiro Suzuki Japan 16 291 0.5× 168 0.3× 93 0.5× 93 0.6× 6 0.0× 59 869

Countries citing papers authored by Luc Darnige

Since Specialization
Citations

This map shows the geographic impact of Luc Darnige's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Darnige with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Darnige more than expected).

Fields of papers citing papers by Luc Darnige

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Darnige. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Darnige. The network helps show where Luc Darnige may publish in the future.

Co-authorship network of co-authors of Luc Darnige

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Darnige. A scholar is included among the top collaborators of Luc Darnige based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Darnige. Luc Darnige is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darnige, Luc, et al.. (2025). Complement in antiphospholipid syndrome, time to target?. Current Opinion in Immunology. 96. 102628–102628.
2.
Aouba, Achille, et al.. (2024). Autoantibodies against complement proteins in patients with antiphospholipid syndrome: Prevalence and clinical associations. European Journal of Immunology. 54(7). e2350832–e2350832. 2 indexed citations
3.
Khider, Lina, Marie Templé, Cécile Bally, et al.. (2022). Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study. Journal of Thrombosis and Haemostasis. 20(11). 2697–2699. 13 indexed citations
4.
Philippe, Aurélien, et al.. (2022). Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up. Annals of Hematology. 101(11). 2453–2460. 2 indexed citations
5.
Gendron, Nicolas, Jean‐Benoît Arlet, Pascale Gaussem, et al.. (2017). Hemolytic anemia, iron deficiency and personal history of deep vein thrombosis: consider paroxysmal nocturnal hemoglobinuria. Annales de biologie clinique. 75(5). 580–588. 2 indexed citations
6.
Dohan, Anthony, Luc Darnige, Marc Sapoval, & Olivier Pellerin. (2015). Spontaneous soft tissue hematomas. Diagnostic and Interventional Imaging. 96(7-8). 789–796. 50 indexed citations
7.
Noël, Nicolas, F. Dutasta, N. Costedoat‐Chalumeau, et al.. (2015). Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome. Autoimmunity Reviews. 14(8). 680–685. 57 indexed citations
9.
Poisson, Johanne, et al.. (2014). Association of chylothorax and direct pleura involvement in a case of Waldenstrom's macroglobulinaemia. Age and Ageing. 43(4). 581–583. 5 indexed citations
10.
Boysson, Hubert de, Luc Darnige, Andrew D. Johnson, et al.. (2014). Syndrome des antiphospholides « séronégatif », syndrome catastrophique, nouveaux anticoagulants : enseignements d’une observation de prise en charge difficile. La Revue de Médecine Interne. 35(11). 752–756. 14 indexed citations
11.
Mumford, Andrew, Shaista P. Nisar, Luc Darnige, et al.. (2013). Platelet dysfunction associated with the novel Trp29Cys thromboxane A2 receptor variant. Journal of Thrombosis and Haemostasis. 11(3). 547–554. 23 indexed citations
12.
Masliah‐Planchon, Julien & Luc Darnige. (2012). Mise au pointAnticorps antiphospholipides et hémostaseAntiphospholipid antibodies and haemostasis. La Revue de Médecine Interne. 33(4). 3 indexed citations
13.
Masliah‐Planchon, Julien & Luc Darnige. (2011). Anticorps antiphospholipides et hémostase. La Revue de Médecine Interne. 33(4). 181–188. 6 indexed citations
14.
Ankri, Annick, et al.. (2010). Hydroxychloroquine: a new approach of thrombosis in the antiphospholipid syndrome.. La Revue de Médecine Interne. 31(12). 854–857. 2 indexed citations
15.
Ugo, Valérie, Sylvie Tondeur, Gérald Le Gac, et al.. (2010). Interlaboratory Development and Validation of a HRM Method Applied to the Detection of JAK2 Exon 12 Mutations in Polycythemia Vera Patients. PLoS ONE. 5(1). e8893–e8893. 27 indexed citations
16.
Ferré, Alexis, et al.. (2008). Hémophilie A acquise précédant l’apparition d’un cancer : quelles explorations et quelle surveillance ?. La Revue de Médecine Interne. 30(7). 630–633. 8 indexed citations
17.
Darnige, Luc, Cécile Legallais, J Arvieux, et al.. (2003). Anti‐β2‐glycoprotein I antibodies recognizing platelet factor 4–heparin complex in antiphospholipid syndrome in patient substantiated with mouse Model. Journal of Molecular Recognition. 16(3). 125–130. 7 indexed citations
19.
Lellouche, Franck, et al.. (1996). Rapid detection of the G1691A mutation of coagulation factor V by PCR-mediated site-directed mutagenesis.. PubMed. 42(2). 329–329. 7 indexed citations
20.
Gruel, Yves, Alain Rupin, Luc Darnige, et al.. (1991). Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay. Thrombosis Research. 62(5). 377–387. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026